242 related articles for article (PubMed ID: 33221434)
1. CRISPR/Cas9-Mediated Gene Correction in Newborn Rabbits with Hereditary Tyrosinemia Type I.
Li N; Gou S; Wang J; Zhang Q; Huang X; Xie J; Li L; Jin Q; Ouyang Z; Chen F; Ge W; Shi H; Liang Y; Zhuang Z; Zhao X; Lian M; Ye Y; Quan L; Wu H; Lai L; Wang K
Mol Ther; 2021 Mar; 29(3):1001-1015. PubMed ID: 33221434
[TBL] [Abstract][Full Text] [Related]
2. Curative Ex Vivo Hepatocyte-Directed Gene Editing in a Mouse Model of Hereditary Tyrosinemia Type 1.
VanLith C; Guthman R; Nicolas CT; Allen K; Du Z; Joo DJ; Nyberg SL; Lillegard JB; Hickey RD
Hum Gene Ther; 2018 Nov; 29(11):1315-1326. PubMed ID: 29764210
[TBL] [Abstract][Full Text] [Related]
3. Cas9-nickase-mediated genome editing corrects hereditary tyrosinemia in rats.
Shao Y; Wang L; Guo N; Wang S; Yang L; Li Y; Wang M; Yin S; Han H; Zeng L; Zhang L; Hui L; Ding Q; Zhang J; Geng H; Liu M; Li D
J Biol Chem; 2018 May; 293(18):6883-6892. PubMed ID: 29507093
[TBL] [Abstract][Full Text] [Related]
4. Fumarylacetoacetate Hydrolase Knock-out Rabbit Model for Hereditary Tyrosinemia Type 1.
Li L; Zhang Q; Yang H; Zou Q; Lai C; Jiang F; Zhao P; Luo Z; Yang J; Chen Q; Wang Y; Newsome PN; Frampton J; Maxwell PH; Li W; Chen S; Wang D; Siu TS; Tam S; Tse HF; Qin B; Bao X; Esteban MA; Lai L
J Biol Chem; 2017 Mar; 292(11):4755-4763. PubMed ID: 28053091
[TBL] [Abstract][Full Text] [Related]
5. Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype.
Yin H; Xue W; Chen S; Bogorad RL; Benedetti E; Grompe M; Koteliansky V; Sharp PA; Jacks T; Anderson DG
Nat Biotechnol; 2014 Jun; 32(6):551-3. PubMed ID: 24681508
[TBL] [Abstract][Full Text] [Related]
6. In utero CRISPR-mediated therapeutic editing of metabolic genes.
Rossidis AC; Stratigis JD; Chadwick AC; Hartman HA; Ahn NJ; Li H; Singh K; Coons BE; Li L; Lv W; Zoltick PW; Alapati D; Zacharias W; Jain R; Morrisey EE; Musunuru K; Peranteau WH
Nat Med; 2018 Oct; 24(10):1513-1518. PubMed ID: 30297903
[TBL] [Abstract][Full Text] [Related]
7. Amelioration of an Inherited Metabolic Liver Disease through Creation of a De Novo Start Codon by Cytidine Base Editing.
Yang L; Wang L; Huo Y; Chen X; Yin S; Hu Y; Zhang X; Zheng R; Geng H; Han H; Ma X; Liu M; Li H; Yu W; Liu M; Wang J; Li D
Mol Ther; 2020 Jul; 28(7):1673-1683. PubMed ID: 32413280
[TBL] [Abstract][Full Text] [Related]
8. Ex vivo gene editing and cell therapy for hereditary tyrosinemia type 1.
Ates I; Stuart C; Rathbone T; Barzi M; He G; Major AM; Shankar V; Lyman RA; Angner SS; Mackay TFC; Srinivasan S; Farris AB; Bissig KD; Cottle RN
Hepatol Commun; 2024 May; 8(5):. PubMed ID: 38668730
[TBL] [Abstract][Full Text] [Related]
9. Self-inactivating, all-in-one AAV vectors for precision Cas9 genome editing via homology-directed repair in vivo.
Ibraheim R; Tai PWL; Mir A; Javeed N; Wang J; Rodríguez TC; Namkung S; Nelson S; Khokhar ES; Mintzer E; Maitland S; Chen Z; Cao Y; Tsagkaraki E; Wolfe SA; Wang D; Pai AA; Xue W; Gao G; Sontheimer EJ
Nat Commun; 2021 Nov; 12(1):6267. PubMed ID: 34725353
[TBL] [Abstract][Full Text] [Related]
10. Efficient liver repopulation of transplanted hepatocyte prevents cirrhosis in a rat model of hereditary tyrosinemia type I.
Zhang L; Shao Y; Li L; Tian F; Cen J; Chen X; Hu D; Zhou Y; Xie W; Zheng Y; Ji Y; Liu M; Li D; Hui L
Sci Rep; 2016 Aug; 6():31460. PubMed ID: 27510266
[TBL] [Abstract][Full Text] [Related]
11. Induced Liver Regeneration Enhances CRISPR/Cas9-Mediated Gene Repair in Tyrosinemia Type 1.
Zhang QS; Tiyaboonchai A; Nygaard S; Baradar K; Major A; Balaji N; Grompe M
Hum Gene Ther; 2021 Mar; 32(5-6):294-301. PubMed ID: 32729326
[TBL] [Abstract][Full Text] [Related]
12. Adeno-associated virus gene repair corrects a mouse model of hereditary tyrosinemia in vivo.
Paulk NK; Wursthorn K; Wang Z; Finegold MJ; Kay MA; Grompe M
Hepatology; 2010 Apr; 51(4):1200-8. PubMed ID: 20162619
[TBL] [Abstract][Full Text] [Related]
13. Gene Editing Successfully Corrects 2 Amino Acid Disorders: In 2 preclinical studies using CRISPR-mediated gene editing, phenylketonuria and hereditary tyrosinemia type 1 were corrected.
Am J Med Genet A; 2019 Jan; 179(1):5-6. PubMed ID: 30681273
[No Abstract] [Full Text] [Related]
14. High volume naked DNA tail-vein injection restores liver function in Fah-knock out mice.
Eggenhofer E; Doenecke A; Renner P; Slowik P; Piso P; Geissler EK; Schlitt HJ; Dahlke MH; Popp FC
J Gastroenterol Hepatol; 2010 May; 25(5):1002-8. PubMed ID: 20546455
[TBL] [Abstract][Full Text] [Related]
15. Curative ex vivo liver-directed gene therapy in a pig model of hereditary tyrosinemia type 1.
Hickey RD; Mao SA; Glorioso J; Elgilani F; Amiot B; Chen H; Rinaldo P; Marler R; Jiang H; DeGrado TR; Suksanpaisan L; O'Connor MK; Freeman BL; Ibrahim SH; Peng KW; Harding CO; Ho CS; Grompe M; Ikeda Y; Lillegard JB; Russell SJ; Nyberg SL
Sci Transl Med; 2016 Jul; 8(349):349ra99. PubMed ID: 27464750
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo.
Yin H; Song CQ; Dorkin JR; Zhu LJ; Li Y; Wu Q; Park A; Yang J; Suresh S; Bizhanova A; Gupta A; Bolukbasi MF; Walsh S; Bogorad RL; Gao G; Weng Z; Dong Y; Koteliansky V; Wolfe SA; Langer R; Xue W; Anderson DG
Nat Biotechnol; 2016 Mar; 34(3):328-33. PubMed ID: 26829318
[TBL] [Abstract][Full Text] [Related]
17. In vivo gene correction with targeted sequence substitution through microhomology-mediated end joining.
Shin JH; Jung S; Ramakrishna S; Kim HH; Lee J
Biochem Biophys Res Commun; 2018 Jul; 502(1):116-122. PubMed ID: 29787760
[TBL] [Abstract][Full Text] [Related]
18. CRISPR/Cas9-mediated genome editing via postnatal administration of AAV vector cures haemophilia B mice.
Ohmori T; Nagao Y; Mizukami H; Sakata A; Muramatsu SI; Ozawa K; Tominaga SI; Hanazono Y; Nishimura S; Nureki O; Sakata Y
Sci Rep; 2017 Jun; 7(1):4159. PubMed ID: 28646206
[TBL] [Abstract][Full Text] [Related]
19. Reprogramming metabolic pathways in vivo with CRISPR/Cas9 genome editing to treat hereditary tyrosinaemia.
Pankowicz FP; Barzi M; Legras X; Hubert L; Mi T; Tomolonis JA; Ravishankar M; Sun Q; Yang D; Borowiak M; Sumazin P; Elsea SH; Bissig-Choisat B; Bissig KD
Nat Commun; 2016 Aug; 7():12642. PubMed ID: 27572891
[TBL] [Abstract][Full Text] [Related]
20. In vivo selection of hepatocytes transduced with adeno-associated viral vectors.
Chen SJ; Tazelaar J; Moscioni AD; Wilson JM
Mol Ther; 2000 May; 1(5 Pt 1):414-22. PubMed ID: 10933962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
